Skip to main content

Pressmeddelanden 1 träff

The first in vitro molecular diagnostic test that can help diagnose early-stage endometrial cancer

The first in vitro molecular diagnostic test that can help diagnose early-stage endometrial cancer

Pressmeddelanden   •   Jun 02, 2014 09:36 CEST

GynEC®-DX is the first in vitro diagnostic test based on molecular analysis of uterine aspirate samples. GynEC®-DX identifies the absence of Type I and Type II cancer, and pre-neoplastic lesions in complex hyperplasia with atypia.